Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer.

Biochemistry

Division of Environmental Health Sciences, College of Public Health, The Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, Ohio 43210, USA.

Published: June 2011

P16(INK4A) (also known as P16 and MTS1), a protein consisting exclusively of four ankyrin repeats, is recognized as a tumor suppressor mainly because of the prevalence of genetic inactivation of the p16(INK4A) (or CDKN2A) gene in virtually all types of human cancers. However, it has also been shown that an elevated level of expression (upregulation) of P16 is involved in cellular senescence, aging, and cancer progression, indicating that the regulation of P16 is critical for its function. Here, we discuss the regulatory mechanisms of P16 function at the DNA level, the transcription level, and the posttranscriptional level, as well as their implications for the structure-function relationship of P16 and for human cancers.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3127263PMC
http://dx.doi.org/10.1021/bi200642eDOI Listing

Publication Analysis

Top Keywords

regulatory mechanisms
8
tumor suppressor
8
human cancers
8
p16
5
mechanisms tumor
4
suppressor p16ink4a
4
p16ink4a relevance
4
relevance cancer
4
cancer p16ink4a
4
p16ink4a p16
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!